Solicitation of Nominations for Membership To Serve on the Advisory Committee on Heritable Disorders in Newborns and Children, 17308-17309 [2022-06367]

Download as PDF jspears on DSK121TN23PROD with NOTICES1 17308 Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices after the date that is 1 year from the Secretary’s adoption of the condition. ACHDNC also provides advice and recommendations to the Secretary concerning grants, projects and technical information to develop policies and priorities for grants, including those that will enhance the ability of the state and local health agencies to provide for newborn and child screening, counseling, and health care services for newborns and children having or at risk for heritable disorders. ACHDNC meets four times each calendar year, or at the discretion of the DFO in consultation with the Chair. Nominations: The Committee may invite organizations to designate individuals to serve as non-voting liaisons. Organizations should demonstrate wide-ranging newborn screening and heritable disorders interests. In addition, the organization’s work should inform the activities of the Committee. Eligible organizations must represent national public health constituencies, medical professional societies, or organizations with large, broad constituencies and broad interest or involvement in newborn screening. Organizations that represent narrow interests (e.g., interest in a single disease treatment) or smaller constituencies are not eligible. Organizational representatives attend Committee meetings to provide relevant expertise and perspectives to Committee members during their deliberations and discussions, but they do not vote and are not official members of the Committee. Applications must contain a cover letter and statement. The cover letter should include the organization name and mission statement; contact information for the designated representative, including point of contact name, address, email, telephone number; and website of the organization. The statement should include the perspective and expertise provided by the organization and its relevance to the Committee; description of how the Committee’s work affects and impacts the organization and its constituency; a list of organizational projects, programs, and products that are of relevance to the Committee’s work; an affirmation of the organization’s commitment to identify a representative with expertise who can attend Committee meetings in person (when applicable) and provide input to the Committee at the discretion of the Chair; an affirmation of the organization’s commitment to financially support (e.g., cover travel expenses) a representative to attend any in-person Committee meetings held in VerDate Sep<11>2014 17:30 Mar 25, 2022 Jkt 256001 Rockville, Maryland; an affirmation of the organization’s commitment to ensure active contribution to and dissemination of Committee activities and recommendations to its constituencies; affirmation the designated representative is able to serve as the liaison; and an affirmation that the organization has no conflict of interest that would preclude informing the Committee in a fair and balanced manner. If there are potential conflicts of interest, please detail the information concerning any potential conflicts of interest relative to both the organization and the proposed organizational representative (e.g., current or anticipated employment, consultancies, research grants, or contracts), as well as how the organization proposes to address the potential conflict. Organizations are eligible to send a representative as long as the organization’s subject area of expertise and mission is relevant to the Committee’s purpose, objective, scope of activities and duties, and as long as the organization actively participates in Committee activities. Every 3 years, the Chair and DFO will re-assess the organization’s mission, relevancy, and benefit as it relates to the Committee’s purpose, objective, scope of activities and duties. Every 3 years, current organizations will be asked to reaffirm their commitment to support an organizational representative. The selection of eligible organizations is based on a review of the organization’s subject area of expertise, mission, relevancy, and benefit as it relates to the Committee’s purpose. Authority: Section 1111(g) of the Public Health Service Act, 42 U.S.C. 300b–10(g), Section 222 of the Public Health Service Act, 42 U.S.C. 217a, and the Federal Advisory Committee Act, 5 U.S.C. App. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–06368 Filed 3–25–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Solicitation of Nominations for Membership To Serve on the Advisory Committee on Heritable Disorders in Newborns and Children Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). AGENCY: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 ACTION: Request for nominations. HRSA is seeking nominations of qualified candidates for consideration for appointment as members of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC or Committee). ACHDNC provides advice, recommendations, and technical information about aspects of heritable disorders and newborn and childhood screening to the Secretary of HHS (Secretary). HRSA is seeking nominations of qualified candidates for appointment to two positions on the Committee beginning in 2023, each serving a term of up-to 4 years. DATES: Written nominations for membership on the Committee must be received on or before April 11, 2022. ADDRESSES: Nomination packages must be submitted electronically as email attachments to Soohyun Kim, MPH, CPH, Acting Designated Federal Officer (DFO) at ACHDNC@hrsa.gov. FOR FURTHER INFORMATION CONTACT: Acting DFO Soohyun Kim, MPH, CPH; Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room 18–N– 38A, Rockville, MD 20857; 301–594– 4202; or ACHDNC@hrsa.gov. A copy of the Committee charter and list of the current membership is available on the Committee’s website at https:// www.hrsa.gov/advisory-committees/ heritable-disorders/about/. SUPPLEMENTARY INFORMATION: ACHDNC was established in 2003 to provide advice and recommendations to the Secretary on the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. ACHDNC reviews and reports regularly on newborn and childhood screening practices for heritable disorders, recommends improvements in the national newborn and childhood heritable screening programs, recommends conditions for inclusion in the Recommended Uniform Screening Panel (RUSP), and fulfills requirements stated in the authorizing legislation. ACHDNC’s recommendations regarding inclusion of additional conditions/inherited disorders for screening that, when adopted by the Secretary, are included in the RUSP, and constitute part of the evidence-informed comprehensive preventive health services guidelines supported by HRSA pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 300gg–13). Under this provision, non-grandfathered group health plans and group and individual SUMMARY: E:\FR\FM\28MRN1.SGM 28MRN1 jspears on DSK121TN23PROD with NOTICES1 Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices health insurance issuers are required to provide insurance coverage without cost-sharing (a co-payment, coinsurance, or deductible) for preventive services for plan years (i.e., in the individual market, policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition. ACHDNC also provides advice and recommendations to the Secretary concerning grants, projects and technical information to develop policies and priorities for grants, including those that will enhance the ability of the state and local health agencies to provide for newborn and child screening, counseling, and health care services for newborns and children having or at risk for heritable disorders. ACHDNC meets four times each calendar year, or at the discretion of the Acting DFO in consultation with the Chair. Nominations: HRSA is requesting nominations for voting members to serve as Special Government Employees (SGEs) on the ACHDNC to fill two positions starting in 2023. The Secretary appoints ACHDNC members with the expertise needed to fulfill the duties of the Committee. The membership requirements are set forth in Title XI § 1111(g), 42 U.S.C. 300b–10(g). Nominees sought are medical, technical, or scientific professionals with special expertise in the field of heritable disorders or in providing screening, counseling, testing, or specialty services for newborns and children with, or at risk for having, heritable disorders; individuals who have expertise in ethics (e.g., bioethics) and infectious diseases and who have worked and published material in the area of newborn screening; members of the public having demonstrated expertise about or concern with heritable disorders; and/or representatives from such federal agencies, public health constituencies, and medical professional societies with such expertise. Interested applicants may self-nominate or be nominated by another individual or organization. Individuals selected for appointment to the Committee will be invited to serve for a term of up-to 4 years. Members appointed as SGEs receive a stipend and reimbursement for per diem and travel expenses incurred for attending ACHDNC meetings and/or conducting other business on behalf of ACHDNC, as authorized by 5 U.S.C. 5703 for persons employed intermittently in government service. The following information must be included in the package of materials submitted for each individual nominated for consideration: (1) A VerDate Sep<11>2014 17:30 Mar 25, 2022 Jkt 256001 statement that includes the name and affiliation of the nominee and a clear statement regarding the basis for the nomination, including the area(s) of demonstrated expertise or concern that may support eligibility of a nominee for service on the Committee, as described above; (2) confirmation the nominee is willing to serve as a member of the Committee; (3) the nominee’s contact information (please include home address, work address, daytime telephone number, and an email address); and (4) a current copy of the nominee’s curriculum vitae. Nomination packages may be submitted directly by the individual being nominated or by the person/ organization recommending the candidate. HHS endeavors to ensure that the membership of ACHDNC is fairly balanced in terms of points of view represented and that individuals from a broad representation of geographic areas, gender, and ethnic and minority groups, as well as individuals with disabilities, are considered for membership. Appointments shall be made without discrimination on the basis of age, ethnicity, gender, sexual orientation, or cultural, religious, or socioeconomic status. Individuals selected for further consideration for appointment will be required to provide detailed information regarding their financial holdings, consultancies, and research grants or contracts. Disclosure of this information is required in order for HRSA ethics officials to determine whether there is a potential conflict of interest between the SGE’s public duties as a member of ACHDNC and their private interests, including an appearance of a loss of impartiality as defined by federal laws and regulations, and to identify any required remedial action needed to address the potential conflict. Authority: Section 1111(g) of the Public Health Service Act, 42 U.S.C 300b–10(g), Section 222 of the Public Health Service Act, 42 U.S.C. 217a, and the Federal Advisory Committee Act, 5 U.S.C. App. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–06367 Filed 3–25–22; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 17309 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Telehealth Resource Center Performance Measurement Tool, OMB No. 0915– 0361—Extension Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In compliance with of the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA’s ICR only after the 30-day comment period for this Notice has closed. SUMMARY: Comments on this ICR should be received no later than April 27, 2022. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email Samantha Miller, the acting HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443–9094. SUPPLEMENTARY INFORMATION: Information Collection Request Title: Telehealth Resource Center (TRC) Performance Measurement Tool, OMB No. 0915–0361—Extension. Abstract: HRSA requests an extension of their TRC Performance Measurement Tool. The TRCs deliver telehealth technical assistance. There are two types of HRSA TRC programs: • Two National Telehealth Resource Center Programs focus on policy and technology. • Twelve Regional Telehealth Resource Center Programs host activities and provide resources to rural and underserved areas. DATES: E:\FR\FM\28MRN1.SGM 28MRN1

Agencies

[Federal Register Volume 87, Number 59 (Monday, March 28, 2022)]
[Notices]
[Pages 17308-17309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Solicitation of Nominations for Membership To Serve on the 
Advisory Committee on Heritable Disorders in Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION:  Request for nominations.

-----------------------------------------------------------------------

SUMMARY: HRSA is seeking nominations of qualified candidates for 
consideration for appointment as members of the Advisory Committee on 
Heritable Disorders in Newborns and Children (ACHDNC or Committee). 
ACHDNC provides advice, recommendations, and technical information 
about aspects of heritable disorders and newborn and childhood 
screening to the Secretary of HHS (Secretary). HRSA is seeking 
nominations of qualified candidates for appointment to two positions on 
the Committee beginning in 2023, each serving a term of up-to 4 years.

DATES: Written nominations for membership on the Committee must be 
received on or before April 11, 2022.

ADDRESSES: Nomination packages must be submitted electronically as 
email attachments to Soohyun Kim, MPH, CPH, Acting Designated Federal 
Officer (DFO) at [email protected].

FOR FURTHER INFORMATION CONTACT: Acting DFO Soohyun Kim, MPH, CPH; 
Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room 18-N-
38A, Rockville, MD 20857; 301-594-4202; or [email protected]. A copy of 
the Committee charter and list of the current membership is available 
on the Committee's website at https://www.hrsa.gov/advisory-committees/heritable-disorders/about/.

SUPPLEMENTARY INFORMATION: ACHDNC was established in 2003 to provide 
advice and recommendations to the Secretary on the development of 
newborn screening activities, technologies, policies, guidelines, and 
programs for effectively reducing morbidity and mortality in newborns 
and children having, or at risk for, heritable disorders. ACHDNC 
reviews and reports regularly on newborn and childhood screening 
practices for heritable disorders, recommends improvements in the 
national newborn and childhood heritable screening programs, recommends 
conditions for inclusion in the Recommended Uniform Screening Panel 
(RUSP), and fulfills requirements stated in the authorizing 
legislation. ACHDNC's recommendations regarding inclusion of additional 
conditions/inherited disorders for screening that, when adopted by the 
Secretary, are included in the RUSP, and constitute part of the 
evidence-informed comprehensive preventive health services guidelines 
supported by HRSA pursuant to section 2713 of the Public Health Service 
Act (42 U.S.C. 300gg-13). Under this provision, non-grandfathered group 
health plans and group and individual

[[Page 17309]]

health insurance issuers are required to provide insurance coverage 
without cost-sharing (a co-payment, co-insurance, or deductible) for 
preventive services for plan years (i.e., in the individual market, 
policy years) beginning on or after the date that is 1 year from the 
Secretary's adoption of the condition.
    ACHDNC also provides advice and recommendations to the Secretary 
concerning grants, projects and technical information to develop 
policies and priorities for grants, including those that will enhance 
the ability of the state and local health agencies to provide for 
newborn and child screening, counseling, and health care services for 
newborns and children having or at risk for heritable disorders.
    ACHDNC meets four times each calendar year, or at the discretion of 
the Acting DFO in consultation with the Chair.
    Nominations: HRSA is requesting nominations for voting members to 
serve as Special Government Employees (SGEs) on the ACHDNC to fill two 
positions starting in 2023. The Secretary appoints ACHDNC members with 
the expertise needed to fulfill the duties of the Committee. The 
membership requirements are set forth in Title XI Sec.  1111(g), 42 
U.S.C. 300b-10(g). Nominees sought are medical, technical, or 
scientific professionals with special expertise in the field of 
heritable disorders or in providing screening, counseling, testing, or 
specialty services for newborns and children with, or at risk for 
having, heritable disorders; individuals who have expertise in ethics 
(e.g., bioethics) and infectious diseases and who have worked and 
published material in the area of newborn screening; members of the 
public having demonstrated expertise about or concern with heritable 
disorders; and/or representatives from such federal agencies, public 
health constituencies, and medical professional societies with such 
expertise. Interested applicants may self-nominate or be nominated by 
another individual or organization.
    Individuals selected for appointment to the Committee will be 
invited to serve for a term of up-to 4 years. Members appointed as SGEs 
receive a stipend and reimbursement for per diem and travel expenses 
incurred for attending ACHDNC meetings and/or conducting other business 
on behalf of ACHDNC, as authorized by 5 U.S.C. 5703 for persons 
employed intermittently in government service.
    The following information must be included in the package of 
materials submitted for each individual nominated for consideration: 
(1) A statement that includes the name and affiliation of the nominee 
and a clear statement regarding the basis for the nomination, including 
the area(s) of demonstrated expertise or concern that may support 
eligibility of a nominee for service on the Committee, as described 
above; (2) confirmation the nominee is willing to serve as a member of 
the Committee; (3) the nominee's contact information (please include 
home address, work address, daytime telephone number, and an email 
address); and (4) a current copy of the nominee's curriculum vitae. 
Nomination packages may be submitted directly by the individual being 
nominated or by the person/organization recommending the candidate.
    HHS endeavors to ensure that the membership of ACHDNC is fairly 
balanced in terms of points of view represented and that individuals 
from a broad representation of geographic areas, gender, and ethnic and 
minority groups, as well as individuals with disabilities, are 
considered for membership. Appointments shall be made without 
discrimination on the basis of age, ethnicity, gender, sexual 
orientation, or cultural, religious, or socioeconomic status.
    Individuals selected for further consideration for appointment will 
be required to provide detailed information regarding their financial 
holdings, consultancies, and research grants or contracts. Disclosure 
of this information is required in order for HRSA ethics officials to 
determine whether there is a potential conflict of interest between the 
SGE's public duties as a member of ACHDNC and their private interests, 
including an appearance of a loss of impartiality as defined by federal 
laws and regulations, and to identify any required remedial action 
needed to address the potential conflict.
    Authority: Section 1111(g) of the Public Health Service Act, 42 
U.S.C 300b-10(g), Section 222 of the Public Health Service Act, 42 
U.S.C. 217a, and the Federal Advisory Committee Act, 5 U.S.C. App.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-06367 Filed 3-25-22; 8:45 am]
BILLING CODE 4165-15-P